/newsroom/taxonomy/term/3734/all en /newsroom/channels/news/study-sheds-light-how-immune-system-protects-body-348205 <p>First <a href="https://doi.org/10.1016/j.cell.2022.12.038">study</a> of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving ±«ÓćÖ±²„, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.</p> Fri, 05 May 2023 18:41:23 +0000 shirley.cardenas@mcgill.ca 299312 at /newsroom /newsroom/channels/news/new-study-uncovers-vast-variation-and-significant-deficits-tuberculosis-care-urban-india-290004 <p>On September 26, Heads of State will gather in New York at the United Nations (UN) General Assemblyā€™s first-ever high-level meeting on tuberculosis (TB) to accelerate efforts to end TB and reach all affected people with prevention and care.</p> Tue, 25 Sep 2018 18:12:59 +0000 justin.dupuis@mcgill.ca 85035 at /newsroom /newsroom/channels/news/complete-make-over-fight-multidrug-resistant-tuberculosis-289423 <p>Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick Menzies, senior scientist at the Research Institute of the ±«ÓćÖ±²„ Health Centre (RI-MUHC) in Montreal. These findings precipitated a complete overhaul of worldwide TB treatment guidelines, with the results of this work published today in the British medical journal <i>The Lancet</i>.</p> Fri, 07 Sep 2018 19:59:02 +0000 justin.dupuis@mcgill.ca 81061 at /newsroom /newsroom/channels/news/latent-tb-treatment-shorter-better-288462 <p>Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the ±«ÓćÖ±²„ Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard. These findings are published today in the New England Journal of Medicine.</p> Thu, 02 Aug 2018 13:38:58 +0000 cynthia.lee@mcgill.ca 66316 at /newsroom /newsroom/channels/news/beyond-killing-tuberculosis-287156 <p>Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective has recently been challenged as scientists have taken a lesson from plant biologists about an ancient strategy involving the ability to ā€œtolerateā€ rather than ā€œresistā€ infection to maintain health. This concept, referred to as ā€œdisease toleranceā€, provides an opportunity to develop new strategies that mitigate the consequences of infection.</p> Fri, 11 May 2018 19:03:57 +0000 justin.dupuis@mcgill.ca 39879 at /newsroom /newsroom/channels/news/re-programming-innate-immune-cells-fight-tuberculosis-283809 <p align="center"> Thu, 11 Jan 2018 15:59:57 +0000 mona.noonoo@mail.mcgill.ca 32828 at /newsroom /newsroom/channels/news/new-muhc-study-calls-targeted-screening-high-risk-healthcare-workers-tuberculosis-269175 <p> Mon, 31 Jul 2017 17:48:51 +0000 cynthia.lee@mcgill.ca 32120 at /newsroom /newsroom/channels/news/simluated-patient-study-sheds-new-light-antibiotic-use-india-262354 <p><strong><em>±«ÓćÖ±²„ Newsroom</em></strong></p> <p><em>As a result of the overuse or misus<span>e of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the worldā€™s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.</span></em></p> Wed, 24 Aug 2016 01:43:10 +0000 nima.adibpour@mail.mcgill.ca 26101 at /newsroom /newsroom/channels/news/experts-world-tb-day-2016-march-24-259831 <p><a href="http://www.stoptb.org/events/world_tb_day/">World TB Day</a> is held each year on March 24th and aims to build public awareness for tuberculosis. A disease which despite being curable, remains a destructive epidemic in much of the world.</p> Tue, 22 Mar 2016 14:17:18 +0000 vincent.allaire@mcgill.ca 25540 at /newsroom /newsroom/channels/news/5m-malaria-tuberculosis-drug-discovery-research-257396 <p>University of Toronto and ±«ÓćÖ±²„ scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseasesĀ  -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.</p> Thu, 17 Dec 2015 20:34:42 +0000 nima.adibpour@mail.mcgill.ca 25046 at /newsroom /newsroom/channels/news/world-tuberculosis-day-march-24-243715 Fri, 20 Mar 2015 19:37:11 +0000 melody.enguix@mcgill.ca 22311 at /newsroom /newsroom/channels/news/tb-avoiding-and-subverting-immunity-240880 Mon, 22 Dec 2014 21:44:23 +0000 melody.enguix@mcgill.ca 21768 at /newsroom /newsroom/channels/news/clerk-pai-named-rsc%E2%80%99s-college-new-scholars-238926 Tue, 16 Sep 2014 17:04:07 +0000 christopher.chipello@mcgill.ca 21139 at /newsroom /newsroom/channels/news/tb-cattle-vaccine-takes-small-step-±«ÓćÖ±²„-219685 <p>Scientists have announced a small but important step in the development of an effective cattle vaccine to prevent bovine tuberculosis. They have identified a "biomarker" using sophisticated molecular technology that allows them to predict vaccine efficacy. David Williams, chairman of the Badger Trust, which strongly supports vaccination of both cattle and badgers, said: "We welcome this refinement in laboratory technique, part of the progress towards the long-awaited goal of an effective cattle vaccine.</p> Tue, 08 Jan 2013 21:38:03 +0000 laurie.devine@mcgill.ca 16019 at /newsroom